4-[(4-Methylpiperazin-1-yl)methyl] benzoic acid dihydrochloride CAS NO.106261-49-8
| Oruko | 4-[(4-Methylpiperazin-1-yl)methyl] benzoic acid dihydrochloride | ||
| CAS RARA. | 106261-49-8 | ||
| Fọọmu Molecular | C13H20Cl2N2O2 | Òṣuwọn Molikula | 307.22 |
| MDL No. | MFCD08060469 | EINECS | 600-728-4 |
| MP | 305-307°C | BP | NA |
| iwuwo | NA | Atọka Refractive | NA |
| FP | NA | Ipo ipamọ | Afẹfẹ inert, Iwọn otutu yara |
|
| |||
| Ifarahan | funfun si pa-funfun gara lulú | ||
| Mimo | 98% | ||
| Ohun elo | Imatinib agbedemeji | ||
| Agbara Ipese | 4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS NO.106261-49-8 jẹ ọja iṣelọpọ nigbagbogbo wa, boya o nilo ayẹwo kekere tabi ẹru nla ti o ju tonnage lọ, ile-iṣẹ wa le pese lodo | ||
| Ti o ba nifẹ si 4- [(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS NO.106261-49-8, lero larọwọto kan si wa jọwọ, ati pe a yoo fun ọ ni awọn ọja didara to dara julọ, idiyele ti o tọ ati ti o dara ju iṣẹ, reti lati wa ifowosowopo. | |
| Imeeli | |
| Nọmba foonu. | +86 139 6251 3054 +86 136 2174 3828 |
Awọn ọja ti a ṣe akojọ nipasẹ ile-iṣẹ pẹlu awọn iwe-aṣẹ, eyiti o jẹ fun iwadi ati idagbasoke nikan kii ṣe fun tita;Awọn ọja iṣakoso yoo ta ni ibamu pẹlu awọn ofin Kannada ati awọn ofin ti orilẹ-ede ti wọn ti ra, ati pe gbogbo awọn ọja ko dara fun lilo eniyan.Ti wọn ba ta, wọn yoo jẹ orilẹ-ede irufin itọsi, gbogbo awọn eewu ti o baamu yoo jẹ gbigbe nipasẹ olura.

![4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS NO.106261-49-8 Aworan ti a ṣe afihan](http://cdn.globalso.com/shlzpharma/106261-49-8-1.jpg)
![4-[(4-Methylpiperazin-1-yl)methyl] benzoic acid dihydrochloride CAS NO.106261-49-8](http://cdn.globalso.com/shlzpharma/106261-49-8-2.jpg)

![5- [4- ((3-Chloro-4-- (3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5](http://cdn.globalso.com/shlzpharma/117.png)

![(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl) Thio] Nonyl] -Estra-1,3,5(10) -Triene-3,17-Diol 17- Acetate CAS NỌ.875573-69-6](http://cdn.globalso.com/shlzpharma/127.png)

